+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Osteoporosis: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Osteoporosis: Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2024
  • 105 Pages
  • Global
From
Substance (Drug) Abuse - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Substance (Drug) Abuse - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 2468 Pages
  • Global
From
Dyslipidemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Dyslipidemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 1761 Pages
  • Global
From
Hyperlipidemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hyperlipidemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 1040 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 155 Pages
  • Global
From
Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 342 Pages
  • Global
From
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2024
  • 95 Pages
  • Global
From
Niemann Pick Type C: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Niemann Pick Type C: Opportunity Assessment and Forecast - Update

  • Report
  • June 2024
  • 54 Pages
  • Global
From
Chronic Kidney Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Chronic Kidney Disease: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 43 Pages
  • Global
From
MELAS Syndrome: Competitive Landscape - Product Thumbnail Image

MELAS Syndrome: Competitive Landscape

  • Report
  • May 2024
  • 65 Pages
  • Global
From
Hypercholesterolemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hypercholesterolemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 1282 Pages
  • Global
From
Pneumococcal Meningitis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Pneumococcal Meningitis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 63 Pages
  • Global
From
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 102 Pages
  • Global
From
Androgenic Alopecia: Competitive Landscape - Product Thumbnail Image

Androgenic Alopecia: Competitive Landscape

  • Report
  • May 2024
  • 72 Pages
  • Global
From
Vitiligo: Competitive Landscape - Product Thumbnail Image

Vitiligo: Competitive Landscape

  • Report
  • May 2024
  • 67 Pages
  • Global
From
Spinal Cord Injury: Competitive Landscape - Product Thumbnail Image

Spinal Cord Injury: Competitive Landscape

  • Report
  • May 2024
  • 74 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032

  • Report
  • May 2024
  • 75 Pages
  • Global
From
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update

  • Report
  • May 2024
  • 92 Pages
  • Global
From
Genital Herpes: Competitive Landscape - Product Thumbnail Image

Genital Herpes: Competitive Landscape

  • Report
  • May 2024
  • 71 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more